Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage IV
Interventions: DRUG: Trastuzumab deruxtecan
Sponsor: Medical University of Vienna
Collaborators: Daiichi Sankyo